AzTrials
AzTrials

Sedentary LifestyleNCT03827239

Investigation of the Effects of Sedentary Behaviour and Moderate Exercise on Glucose Tolerance and Insulin Sensitivity

A study testing Activity/Moderate Exercise in people with Sedentary Lifestyle and Insulin Sensitivity, run by University of Prince Edward Island at 1 site in Canada.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Individuals with pre-diabetes or diabetes would benefit from low impact methods that would improve their insulin sensitivity and aid in maintaining glucose homeostasis. Physical activity helps the body decrease its insulin resistance and burn excess sugar. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
What is being tested?
Activity/Moderate Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteCanada
Study dates
17 Jan 2019to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy
  • BMI between 18-30 kg/m²
  • non-smoker

Who cannot join

  • pregnant
  • diabetes
  • kidney disease
  • liver disease
  • cardiovascular disease
  • cancer

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Prince Edward Island

    Charlottetown, Prince Edward Island, C1A 4P3

Other trials in Canada

About this study

Individuals with pre-diabetes or diabetes would benefit from low impact methods that would improve their insulin sensitivity and aid in maintaining glucose homeostasis. Physical activity helps the body decrease its insulin resistance and burn excess sugar. Many diabetics also suffer from obesity and specific forms or durations of physical exercise may not be viable options for these individuals. Determining whether short bursts of moderate exercise improve blood glucose levels in healthy humans may identify a further method for diabetics to improve their glucose homeostasis.

The aim of this study is to determine the most effective moderate exercise that can be completed in 3 minutes and its effectiveness on improving glucose handling, in response to a single day of standardized high-fat and high-carbohydrate feeding in comparison to periods of prolonged sitting.

Being tested
Activity/Moderate Exercise
Medical subject headings
Sedentary Behavior, Insulin Resistance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Activity/Moderate ExerciseOther

    3-hour sedentary period with 3 minute activity breaks of moderate exercise every 30 minutes

Study groups in NCT03827239
Study groupRoleWhat they receive
ControlNo interventionNo intervention. Study participants will be seated during the entire sedentary 3-hour time period and wheeled to phlebotomy (and exercise) stations when required. During the sedentary period, participants will eat the food according to the study protocol and be seated at desks and allowed to read and use computers.
InterventionExperimentalWill disrupt their sedentary time with 3 minute exercise sessions every 30 minutes
Receives: Other: Activity/Moderate Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Insulin levels

    The change in blood insulin levels from baseline (12 hours fasted) to 3-hours post-prandial will be determined from blood serum using a human metabolic hormone multiplex panel (Luminex xMAP technology).

    Measured: Pre-prandial baseline (12 hours fasted) and 3 hours post-prandial on each of two testing days

  2. Change in concentration of C-peptide

    The change in blood C-peptide levels from baseline (12 hours fasted) to 3-hours post-prandial will be determined from blood serum using a human metabolic hormone multiplex panel (Luminex xMAP technology).

    Measured: Pre-prandial baseline (12 hours fasted) and 3 hours post-prandial on each of two testing days

  3. Changes in blood glucose levels

    Blood glucose levels will be determined at pre-prandial baseline and over the following 3-hour testing period using hand-held blood glucose meters.

    Measured: Baseline and every 30-60 minutes over 3 hours (6 timepoints per test day)

  4. Change in metabolomic response to a test meal

    Targeted metabolomics analysis of approximately 139 metabolites in blood serum by LC-MS/MS to generate a metabolomic profile in response to a high-fat and high-carbohydrate test meal. Metabolites to be determined are categorized as biogenic amines, amino acids, histidines, carboxylic acids, acylcarnitines, glycerophospholipids and organic acids.

    Measured: Pre-prandial and 3-hours post test meal through study completion

Secondary outcomes (6)
  1. Immediate effects of short-term sedentary behaviour on cognitive function

    Assessing cognitive abilities using the Stroop Test.

    Measured: 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  2. Immediate effects of short-term sedentary behaviour on cognitive function

    Assessing cognitive abilities using the Iowa Trail Making Test.

    Measured: 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  3. Immediate effects of short-term sedentary behaviour on cognitive function

    Assessing cognitive abilities using the Digit-Span test.

    Measured: 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  4. Immediate effects of short-term sedentary behaviour on cognitive function

    Assessing cognitive abilities using the N-back test.

    Measured: 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  5. Immediate effects of short-term sedentary behaviour on cognitive function

    Assessing cognitive abilities using the Flankers test.

    Measured: 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  6. Gene expression levels in isolated PBMC populations

    Determining changes in gene expression in pathways associated with RAGE signalling.

    Measured: Pre-prandial and 3 hours post-prandial on on test days through study completion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Feb 2019
  2. Study start17 Jan 2019
  3. Primary completion31 Oct 2019
  4. Study completion31 Dec 2019

Why it stopped: Lack of funding caused us to cancel the study.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03827239
Sponsor's protocol ID
6007895
Status last verified
Jan 2019
First submitted
22 Jan 2019
Last updated
29 Jan 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Activity/Moderate Exercise in people with Sedentary Lifestyle and Insulin Sensitivity, run by University of Prince Edward Island at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 29 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Lack of funding caused us to cancel the study.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Insulin levels (time frame: Pre-prandial baseline (12 hours fasted) and 3 hours post-prandial on each of two testing days). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in